CL
Colgate-Palmolive Company
Stock
$84.26−0.27 (−0.32%)Close Oct 2, 2026
Income statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.0B | $20.4B | $20.1B | $19.5B | $18.0B | $17.4B | $16.5B | $15.7B | $15.5B | $15.5B | $15.2B | $16.0B | $17.3B | $17.4B | $17.1B | $16.7B | $15.6B | $15.3B | $15.3B | $13.8B |
| Cost of revenue | $8.3B | $8.1B | $7.9B | $8.1B | $7.7B | $7.0B | $6.5B | $6.4B | $6.3B | $6.2B | $6.1B | $6.6B | $7.2B | $7.2B | $7.2B | $7.1B | $6.4B | $6.3B | $6.7B | $6.0B |
| Gross profit | $12.7B | $12.3B | $12.2B | $11.3B | $10.2B | $10.4B | $10.0B | $9.3B | $9.2B | $9.3B | $9.1B | $9.4B | $10.1B | $10.2B | $9.9B | $9.6B | $9.2B | $9.0B | $8.6B | $7.7B |
| R&D | — | $366M | $355M | $343M | $320M | $307M | $290M | $281M | $277M | $285M | $289M | $274M | $277M | $267M | $259M | $262M | $256M | $256M | $240M | — |
| SG&A | $8.2B | $7.9B | $7.7B | $7.2B | $6.6B | $6.4B | $6.0B | $5.6B | $5.4B | $5.4B | $5.1B | $5.5B | $6.0B | $6.2B | $5.9B | $5.8B | $5.4B | $5.3B | $5.4B | $5.0B |
| Other operating expenses | $1.3B | $676M | — | — | $470M | $329M | — | — | — | — | — | $872M | $293M | $155M | — | — | $45M | — | — | $54M |
| Operating income | $3.1B | $3.3B | $4.3B | $4.0B | $2.9B | $3.3B | $3.9B | $3.6B | $3.7B | $3.7B | $4.0B | $2.8B | $3.6B | $3.6B | $3.9B | $3.8B | $3.5B | $3.6B | $3.1B | $2.7B |
| Non-operating income | −$189M | −$247M | −$312M | −$592M | −$233M | −$245M | −$238M | −$253M | −$230M | −$220M | −$217M | −$26M | −$24M | $9.0M | −$15M | −$52M | −$59M | −$77M | — | — |
| Pretax income | $2.9B | $3.1B | $4.0B | $3.4B | $2.7B | $3.1B | $3.6B | $3.3B | $3.5B | $3.5B | $3.7B | $2.8B | $3.5B | $3.6B | $3.9B | $3.8B | $3.4B | $3.5B | — | — |
| Taxes | $905M | $927M | $1.1B | $1.1B | $875M | $921M | $952M | $934M | $1.1B | $1.5B | $1.3B | $1.4B | $1.4B | $1.3B | $1.4B | $1.4B | $1.2B | $1.2B | — | — |
| Net income | $2.0B | $2.1B | $2.9B | $2.3B | $1.8B | $2.2B | $2.7B | $2.4B | $2.4B | $2.0B | $2.4B | $1.4B | $2.2B | $2.2B | $2.5B | $2.4B | $2.2B | $2.3B | $2.0B | $1.7B |
| Diluted EPS | $2.52 | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 | $3.14 | $2.75 | $2.75 | $2.28 | $2.72 | $1.52 | $2.36 | $2.38 | $2.57 | $2.47 | $2.16 | $2.19 | $1.83 | $1.60 |
| Diluted shares | — | 811.1M | 823.2M | 829.2M | 838.8M | 848.3M | 859.3M | 861.1M | 873.0M | 887.8M | 898.4M | 909.7M | 924.3M | 939.9M | 960.2M | 984.1M | 1.02B | 1.05B | 1.07B | — |
| Revenue growth | — | +1.4% | +3.3% | +8.3% | +3.1% | +5.8% | +5.0% | +1.0% | +0.6% | +1.7% | −5.2% | −7.2% | −0.8% | +2.0% | +2.1% | +7.5% | +1.5% | 0.0% | +11.2% | — |
| Gross margin | 60.4% | 60.1% | 60.5% | 58.2% | 57.0% | 59.6% | 60.8% | 59.4% | 59.4% | 60.0% | 60.0% | 58.6% | 58.5% | 58.6% | 58.1% | 57.3% | 59.1% | 58.8% | 56.3% | 56.2% |
| Operating margin | 14.9% | 16.2% | 21.2% | 20.5% | 16.1% | 19.1% | 23.6% | 22.6% | 23.8% | 24.0% | 26.0% | 17.4% | 20.6% | 20.4% | 22.8% | 23.0% | 22.4% | 23.6% | 20.2% | 19.7% |
| Net margin | 9.7% | 10.5% | 14.4% | 11.8% | 9.9% | 12.4% | 16.4% | 15.1% | 15.4% | 13.1% | 16.1% | 8.6% | 12.6% | 12.9% | 14.5% | 14.5% | 14.2% | 14.9% | 12.8% | 12.6% |